Exactech Company Profile (NASDAQ:EXAC)

About Exactech (NASDAQ:EXAC)

Exactech logoExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:EXAC
  • CUSIP: 30064E10
  • Web: www.exac.com
  • Market Cap: $440.81 million
  • Outstanding Shares: 14,312,000
Average Prices:
  • 50 Day Moving Avg: $28.88
  • 200 Day Moving Avg: $26.86
  • 52 Week Range: $22.20 - $31.05
  • Trailing P/E Ratio: 1283.33
  • Foreward P/E Ratio: 20.95
  • P/E Growth: 2.32
Sales & Book Value:
  • Annual Revenue: $261.76 million
  • Price / Sales: 1.68
  • Book Value: $16.79 per share
  • Price / Book: 1.83
  • EBIDTA: $42.88 million
  • Net Margins: 6.34%
  • Return on Equity: 6.81%
  • Return on Assets: 5.53%
  • Debt-to-Equity Ratio: 0.08%
  • Current Ratio: 4.75%
  • Quick Ratio: 2.21%
  • Average Volume: 30,588 shs.
  • Beta: 0.84
  • Short Ratio: 3.72

Frequently Asked Questions for Exactech (NASDAQ:EXAC)

What is Exactech's stock symbol?

Exactech trades on the NASDAQ under the ticker symbol "EXAC."

How were Exactech's earnings last quarter?

Exactech, Inc. (NASDAQ:EXAC) announced its quarterly earnings results on Tuesday, April, 25th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.31 by $0.03. The company earned $69.48 million during the quarter, compared to analyst estimates of $67.05 million. Exactech had a return on equity of 6.81% and a net margin of 6.34%. The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. View Exactech's Earnings History.

When will Exactech make its next earnings announcement?

Exactech is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Exactech.

What guidance has Exactech issued on next quarter's earnings?

Exactech updated its FY17 earnings guidance on Tuesday, April, 25th. The company provided earnings per share guidance of $1.26 - $1.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.29. The company issued revenue guidance of $266 million - $272 million, compared to the consensus revenue estimate of $267.87 million.Exactech also updated its Q2 guidance to $0.32 - $0.34 EPS.

Are investors shorting Exactech?

Exactech saw a increase in short interest in the month of May. As of May 15th, there was short interest totalling 92,693 shares, an increase of 8.4% from the April 28th total of 85,543 shares. Based on an average daily trading volume, of 25,976 shares, the days-to-cover ratio is currently 3.6 days.

Who are some of Exactech's key competitors?

Who are Exactech's key executives?

Exactech's management team includes the folowing people:

  • R William Petty, Executive Chairman of the Board
  • David W. Petty, Chief Executive Officer, Director
  • Joel C. Phillips CPA, Chief Financial Officer, Treasurer
  • Bruce E. Thompson, Senior Vice President , General manager- Biologics Division
  • Gary J. Miller Ph.D., Executive Vice President - Research and Development
  • Donna M. Edwards, Vice President - Legal
  • Betty A. Petty, Vice President - Administration, Corporate Secretary
  • W. Andrew Krusen Jr., Director
  • James G. Binch, Independent Director
  • William B. Locander Ph.D., Independent Director

Who owns Exactech stock?

Exactech's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Wellington Management Group LLP (9.45%), Dimensional Fund Advisors LP (5.45%), Acadian Asset Management LLC (3.19%), LSV Asset Management (2.96%), Vanguard Group Inc. (2.86%) and Royce & Associates LP (2.03%). Company insiders that own Exactech stock include Betty A Petty, Bruce E Thompson, David W Petty, Donna M Edwards, Fern Watts, Gary J Miller, James G Binch, Joel C Phillips and William B Locander. View Institutional Ownership Trends for Exactech.

Who sold Exactech stock? Who is selling Exactech stock?

Exactech's stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Russell Investments Group Ltd., Morgan Stanley, Acadian Asset Management LLC, Cornerstone Capital Management Holdings LLC., Clean Yield Group, LSV Asset Management and Teachers Advisors LLC. Company insiders that have sold Exactech stock in the last year include Bruce E Thompson, David W Petty, Fern Watts, Gary J Miller, James G Binch and Joel C Phillips. View Insider Buying and Selling for Exactech.

Who bought Exactech stock? Who is buying Exactech stock?

Exactech's stock was bought by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc., Foundry Partners LLC, Royce & Associates LP, TFS Capital LLC, Rice Hall James & Associates LLC, Dimensional Fund Advisors LP, Spark Investment Management LLC and Vanguard Group Inc.. View Insider Buying and Selling for Exactech.

How do I buy Exactech stock?

Shares of Exactech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactech's stock price today?

One share of Exactech stock can currently be purchased for approximately $30.80.

MarketBeat Community Rating for Exactech (NASDAQ EXAC)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  126
MarketBeat's community ratings are surveys of what our community members think about Exactech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Exactech (NASDAQ:EXAC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Exactech (NASDAQ:EXAC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/13/2016Robert W. BairdUpgradeNeutral -> Outperform$21.00 -> $26.00N/AView Rating Details
10/28/2015Northland SecuritiesLower Price TargetMarket Perform$22.00 -> $20.00N/AView Rating Details
7/29/2015Canaccord GenuityReiterated RatingHold$22.00N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Exactech (NASDAQ:EXAC)
Earnings by Quarter for Exactech (NASDAQ:EXAC)
Earnings History by Quarter for Exactech (NASDAQ:EXAC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017Q1 2017$0.31$0.34$67.05 million$69.48 millionViewN/AView Earnings Details
2/21/2017Q416$0.32$0.34$66.00 million$66.20 millionViewListenView Earnings Details
10/31/2016Q316$0.22$0.22$58.69 million$59.90 millionViewN/AView Earnings Details
8/1/2016Q216$0.30$0.31$64.18 million$66.10 millionViewN/AView Earnings Details
4/26/2016Q116$0.29$0.31$63.63 million$65.30 millionViewN/AView Earnings Details
2/16/2016Q415$0.28$0.29$61.29 million$62.70 millionViewListenView Earnings Details
10/27/2015Q315$0.23$0.20$58.46 million$56.20 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.26$62.13 million$61.50 millionViewListenView Earnings Details
4/28/2015Q115$0.30$0.29$63.71 million$61.40 millionViewN/AView Earnings Details
2/17/2015Q414$0.33$0.36$63.30 million$63.30 millionViewN/AView Earnings Details
10/21/2014Q314$0.25$0.21$58.60 million$57.90 millionViewN/AView Earnings Details
7/28/2014Q214$0.30$0.30$63.80 million$63.92 millionViewN/AView Earnings Details
4/21/2014Q114$0.29$0.30$63.05 million$63.30 millionViewN/AView Earnings Details
2/19/2014Q413$0.31$0.33$63.20 million$61.60 millionViewN/AView Earnings Details
10/22/2013Q313$0.21$0.23$55.36 million$55.70 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.25$0.27$58.42 million$60.60 millionViewN/AView Earnings Details
2/26/2013Q4 2012$0.28$0.29$58.20 million$59.30 millionViewN/AView Earnings Details
10/30/2012Q312$0.17$0.19$50.20 million$51.30 millionViewN/AView Earnings Details
7/31/2012$0.23$0.23ViewN/AView Earnings Details
5/1/2012$0.23$0.25ViewN/AView Earnings Details
2/28/2012$0.25$0.18ViewN/AView Earnings Details
11/1/2011$0.20$0.15ViewN/AView Earnings Details
8/2/2011$0.26$0.28ViewN/AView Earnings Details
5/3/2011$0.27$0.28ViewN/AView Earnings Details
2/28/2011$0.23$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Exactech (NASDAQ:EXAC)
Current Year EPS Consensus Estimate: $1.30 EPS
Next Year EPS Consensus Estimate: $1.47 EPS


Dividend History for Exactech (NASDAQ:EXAC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Exactech (NASDAQ:EXAC)
Insider Ownership Percentage: 29.80%
Institutional Ownership Percentage: 64.24%
Insider Trades by Quarter for Exactech (NASDAQ:EXAC)
Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)
Insider Trades by Quarter for Exactech (NASDAQ:EXAC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2017Joel C PhillipsCFOSell7,610$30.71$233,703.10View SEC Filing  
3/9/2017Fern WattsDirectorSell1,000$24.25$24,250.00View SEC Filing  
3/8/2017James G BinchDirectorSell3,588$24.16$86,686.08View SEC Filing  
2/24/2017Bruce E ThompsonSVPSell4,906$24.77$121,521.62View SEC Filing  
11/3/2016James G BinchDirectorSell600$22.61$13,566.00View SEC Filing  
8/25/2016Fern WattsDirectorSell1,100$27.68$30,448.00View SEC Filing  
8/22/2016Bruce E ThompsonSVPSell1,433$27.97$40,081.01View SEC Filing  
8/19/2016David W PettyCEOSell3,550$27.75$98,512.50View SEC Filing  
7/1/2016Joel C PhillipsCFOSell3,000$26.75$80,250.00View SEC Filing  
6/8/2016Gary J MillerEVPSell9,800$25.16$246,568.00View SEC Filing  
6/7/2016Bruce E ThompsonSVPSell2,000$25.07$50,140.00View SEC Filing  
6/3/2016James G BinchDirectorSell600$24.86$14,916.00View SEC Filing  
6/2/2016Gary J MillerEVPSell3,381$25.11$84,896.91View SEC Filing  
5/25/2016Gary J MillerEVPSell9,319$25.10$233,906.90View SEC Filing  
5/18/2016Gary J MillerEVPSell9,664$24.37$235,511.68View SEC Filing  
5/9/2016Joel C PhillipsCFOSell3,900$23.13$90,207.00View SEC Filing  
5/5/2016James G BinchDirectorSell1,870$23.00$43,010.00View SEC Filing  
5/3/2016Fern WattsDirectorSell2,000$22.76$45,520.00View SEC Filing  
4/29/2016Betty A PettyVPSell18,000$22.65$407,700.00View SEC Filing  
4/27/2016Gary J MillerEVPSell9,851$24.06$237,015.06View SEC Filing  
4/26/2016Gary J MillerEVPSell7,985$23.11$184,533.35View SEC Filing  
4/25/2016Gary J MillerEVPSell4,725$23.14$109,336.50View SEC Filing  
3/31/2016Gary J MillerEVPSell7,000$19.95$139,650.00View SEC Filing  
3/10/2016Joel C PhillipsCFOSell2,000$18.58$37,160.00View SEC Filing  
3/8/2016Betty A PettyVPSell15,964$19.06$304,273.84View SEC Filing  
3/7/2016Donna M EdwardsVPSell10,000$18.85$188,500.00View SEC Filing  
3/3/2016Gary J MillerEVPSell7,017$19.23$134,936.91View SEC Filing  
3/3/2016William B LocanderDirectorSell2,435$19.25$46,873.75View SEC Filing  
12/10/2015James G BinchDirectorSell1,500$17.03$25,545.00View SEC Filing  
12/9/2015Fern WattsDirectorSell1,200$17.32$20,784.00View SEC Filing  
12/1/2015Bruce E. ThompsonSVPSell21,904$17.57$384,853.28View SEC Filing  
11/24/2015Bruce E. ThompsonSVPSell900$17.75$15,975.00View SEC Filing  
9/1/2015Bruce E. ThompsonSVPSell2,107$19.45$40,981.15View SEC Filing  
5/28/2015Joel C PhillipsCFOSell5,000$21.76$108,800.00View SEC Filing  
5/20/2015William B LocanderDirectorSell3,350$21.50$72,025.00View SEC Filing  
5/18/2015Fern WattsDirectorSell2,200$21.21$46,662.00View SEC Filing  
5/4/2015Joel C PhillipsCFOSell2,700$21.67$58,509.00View SEC Filing  
3/20/2015Gary J MillerEVPSell32,800$24.95$818,360.00View SEC Filing  
2/24/2015R William PettyChairmanSell45,067$23.08$1,040,146.36View SEC Filing  
2/2/2015Betty A PettyVPSell7,500$20.74$155,550.00View SEC Filing  
1/8/2015Gary J MillerEVPSell4,145$23.17$96,039.65View SEC Filing  
12/3/2014Gary J MillerEVPSell5,000$21.83$109,150.00View SEC Filing  
11/25/2014Betty A PettyMajor ShareholderSell12,500$21.86$273,250.00View SEC Filing  
11/25/2014Bruce E ThompsonSVPSell6,500$22.05$143,325.00View SEC Filing  
10/31/2014Joel C PhillipsCFOSell5,000$21.44$107,200.00View SEC Filing  
9/5/2014R William PettyMajor ShareholderSell25,000$23.68$592,000.00View SEC Filing  
8/25/2014Albert H BursteinDirectorSell8,852$23.73$210,057.96View SEC Filing  
7/1/2014Gary J MillerEVPSell12,392$26.21$324,794.32View SEC Filing  
6/26/2014Gary J MillerEVPSell1,894$25.06$47,463.64View SEC Filing  
6/25/2014Gary J MillerEVPSell16,356$25.33$414,297.48View SEC Filing  
6/10/2014Joel C PhillipsCFOSell5,000$24.77$123,850.00View SEC Filing  
6/5/2014Bruce E ThompsonSVPSell1,667$23.50$39,174.50View SEC Filing  
6/5/2014Joel C PhillipsCFOSell5,000$23.21$116,050.00View SEC Filing  
5/29/2014Bruce E ThompsonSVPSell1,588$23.00$36,524.00View SEC Filing  
5/12/2014David PettyCEOSell10,287$20.99$215,924.13View SEC Filing  
5/8/2014David PettyCEOSell7,976$21.51$171,563.76View SEC Filing  
4/24/2014Bruce ThompsonSVPSell2,412$23.78$57,357.36View SEC Filing  
4/23/2014William LocanderDirectorSell4,500$23.18$104,310.00View SEC Filing  
2/28/2014William LocanderDirectorSell1,819$23.16$42,128.04View SEC Filing  
12/5/2013R William PettyCEOSell10,000$23.67$236,700.00View SEC Filing  
11/12/2013Bruce ThompsonSVPSell3,079$23.35$71,894.65View SEC Filing  
8/22/2013William LocanderDirectorSell1,521$19.05$28,975.05View SEC Filing  
7/15/2013Gary J MillerEVPSell10,250$20.07$205,717.50View SEC Filing  
7/8/2013Gary J MillerEVPSell1,000$20.00$20,000.00View SEC Filing  
6/17/2013Gary J MillerEVPSell8,125$18.98$154,212.50View SEC Filing  
6/5/2013R William PettyCEOSell3,885$18.00$69,930.00View SEC Filing  
6/4/2013R William PettyCEOSell14,257$18.01$256,768.57View SEC Filing  
5/28/2013R William PettyCEOSell20,000$18.21$364,200.00View SEC Filing  
5/22/2013R William PettyCEOSell11,493$18.13$208,368.09View SEC Filing  
5/17/2013R William PettyCEOSell17,472$18.05$315,369.60View SEC Filing  
5/16/2013R William PettyCEOSell22,893$18.22$417,110.46View SEC Filing  
5/9/2013R William PettyCEOSell10,000$18.25$182,500.00View SEC Filing  
5/8/2013David W PettyPresidentSell8,000$18.35$146,800.00View SEC Filing  
12/4/2012R William PettyCEOSell14,048$16.29$228,841.92View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Exactech (NASDAQ:EXAC)
Latest Headlines for Exactech (NASDAQ:EXAC)
americanbankingnews.com logoExactech, Inc. (EXAC) Short Interest Update
www.americanbankingnews.com - May 26 at 9:45 AM
americanbankingnews.com logoJoel C. Phillips Sells 7,610 Shares of Exactech, Inc. (EXAC) Stock
www.americanbankingnews.com - May 25 at 8:06 PM
finance.yahoo.com logoExactech (EXAC) Gets FDA Approval for ExactechGPS Application
finance.yahoo.com - May 19 at 5:40 AM
streetinsider.com logoExactech (EXAC) Gains FDA 510(k) Clearance for ExactechGPS Shoulder Application
www.streetinsider.com - May 16 at 10:02 PM
finance.yahoo.com logoExactech Receives 510(k) Clearance for Computer-Assisted Shoulder Arthroplasty Technology
finance.yahoo.com - May 15 at 11:35 AM
americanbankingnews.com logoExactech (EXAC) Getting Favorable Press Coverage, Study Shows
www.americanbankingnews.com - May 3 at 12:14 AM
marketwatch.com logoVentricular Assist Device (VAD) Market Forecast 2017-2027
www.marketwatch.com - May 2 at 7:32 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - May 1 at 9:28 PM
americanbankingnews.com logoFY2018 EPS Estimates for Exactech, Inc. (EXAC) Lifted by Analyst
www.americanbankingnews.com - May 1 at 2:00 PM
americanbankingnews.com logoFY2021 Earnings Forecast for Exactech, Inc. Issued By Gabelli (EXAC)
www.americanbankingnews.com - April 29 at 12:48 AM
reuters.com logoBRIEF-Exactech reports Q1 earnings per share $0.32
www.reuters.com - April 27 at 10:43 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Upgraded to "B" at TheStreet
www.americanbankingnews.com - April 27 at 4:57 PM
finance.yahoo.com logoEdited Transcript of EXAC earnings conference call or presentation 26-Apr-17 2:00pm GMT
finance.yahoo.com - April 27 at 11:19 AM
americanbankingnews.com logoExactech (EXAC) Getting Somewhat Favorable News Coverage, Report Shows
www.americanbankingnews.com - April 27 at 12:10 AM
americanbankingnews.com logoExactech, Inc. (EXAC) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 25 at 8:50 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Updates Q2 Earnings Guidance
www.americanbankingnews.com - April 25 at 7:02 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Issues FY17 Earnings Guidance
www.americanbankingnews.com - April 25 at 7:02 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Announces Quarterly Earnings Results
www.americanbankingnews.com - April 25 at 6:22 PM
marketbeat.com logoExactech posts 1Q profit
marketbeat.com - April 25 at 4:47 PM
finance.yahoo.com logoExactech Q1 Revenue Up 6% to $69.5 Million on 21% Extremities Growth
finance.yahoo.com - April 25 at 4:46 PM
americanbankingnews.com logoExactech (EXAC) Receives Daily News Sentiment Rating of 0.17
www.americanbankingnews.com - April 23 at 6:34 PM
americanbankingnews.com logoExactech (EXAC) Receiving Very Positive News Coverage, Study Finds
www.americanbankingnews.com - April 19 at 10:30 AM
americanbankingnews.com logo Exactech, Inc. (EXAC) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 17 at 10:10 PM
americanbankingnews.com logoExactech (EXAC) Getting Somewhat Positive Media Coverage, Report Shows
www.americanbankingnews.com - April 15 at 4:03 PM
finance.yahoo.com logoExactech, Inc. breached its 50 day moving average in a Bearish Manner : EXAC-US : April 14, 2017
finance.yahoo.com - April 14 at 10:11 AM
finance.yahoo.com logoExactech Schedules First Quarter 2017 Earnings Release and Conference Call
finance.yahoo.com - April 12 at 5:08 PM
americanbankingnews.com logoExactech, Inc. (EXAC) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 10 at 11:33 PM
finance.yahoo.com logoExactech New Scientific and Clinical Research Presented at 2017 Orthopaedic Research Society Annual Meeting
finance.yahoo.com - March 30 at 5:33 PM
prnewswire.com logoGlobal Market Study on Hip Replacement: North America to Register a CAGR of 4.3% Between 2016 and 2024
www.prnewswire.com - March 16 at 11:28 PM
finance.yahoo.com logoExactech Announces Full Launch of Three Revision Systems and Expansion of Advanced Surgical Technologies at AAOS 2017 Annual Meeting, Exhibit #1433
finance.yahoo.com - March 14 at 12:44 PM
finance.yahoo.com logoExactech Announces Investor Presentation at 12th Annual CanaccordGenuity Musculoskeletal Conference
finance.yahoo.com - March 13 at 11:51 AM
finance.yahoo.com logoEXACTECH INC Financials
finance.yahoo.com - March 11 at 5:04 PM
biz.yahoo.com logoEXACTECH INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 8 at 5:56 PM
bizjournals.com logoKnee Implant Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
www.bizjournals.com - March 7 at 4:55 PM
seekingalpha.com logoExactech's (EXAC) CEO David Petty on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 22 at 5:22 PM
investopedia.com logoExactech Posts Q4 Loss of 82 Cents a Share (EXAC)
www.investopedia.com - February 22 at 5:22 PM
investopedia.com logoExactech Posts Q4 Loss of 82 Cents a Share
www.investopedia.com - February 22 at 5:22 PM
biz.yahoo.com logoQ4 2016 Exactech Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 22 at 8:55 AM
us.rd.yahoo.com logoExactech 2016 Revenue Up 7% to $257.6 Million, Q4’16 Revenue Increased 6% to $66.2 Million
us.rd.yahoo.com - February 22 at 8:55 AM
us.rd.yahoo.com logo8:25 am Exactech beats by $0.04, reports revs in-line; guides Q1 EPS below two analyst estimate, revs in-line; guides FY17 EPS in-line, revs in-line
us.rd.yahoo.com - February 22 at 8:55 AM
finance.yahoo.com logoEdited Transcript of EXAC earnings conference call or presentation 21-Feb-17 3:00pm GMT
finance.yahoo.com - February 22 at 8:55 AM
bizjournals.com logoThese drug and medical device companies made the most payments to N.Y.C. hospitals
www.bizjournals.com - February 14 at 3:54 AM
finance.yahoo.com logoExactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
finance.yahoo.com - February 13 at 5:53 PM
biz.yahoo.com logoEXACTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - February 8 at 5:37 PM
finance.yahoo.com logoKnee Reconstruction Devices Market by Product Type, Partial, and Revision Implants, and Geography - Global Analysis and Forecast to 2020
finance.yahoo.com - February 1 at 5:41 PM
streetinsider.com logoExactech (EXAC) Sells Spine Assets, Announces Restructuring Charges
www.streetinsider.com - January 31 at 5:48 PM
finance.yahoo.com logoExactech Announces Divestiture of Spine Assets and Restructuring Charges
finance.yahoo.com - January 31 at 5:48 PM
finance.yahoo.com logo4:04 pm Exactech divests its Spine & Biologics biz segment; guides FY17 EPS & rev in-line
finance.yahoo.com - January 31 at 5:48 PM
prnewswire.com logoPlatelet Rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
www.prnewswire.com - January 6 at 3:56 AM



Exactech (EXAC) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff